· worldwide. In June 2018, Biocon and Mylan became the first to receive approval for biosimilar...
12
· worldwide. In June 2018, Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the U.S. FDA, ahead of a pack of strong competitors who are also